<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Public Health">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Public Health</JournalTitle>
      <Issn>2251-6085</Issn>
      <Volume>54</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>06</Month>
        <Day>02</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Anticancer effects of Escherichia coli-derived outer membrane vesicles against colorectal cancer cells through regulation of apoptosis</title>
    <FirstPage>1310</FirstPage>
    <LastPage>1319</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Marjan</FirstName>
        <LastName>Ghiyasvand</LastName>
        <affiliation locale="en_US">Department of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ardeshir</FirstName>
        <LastName>hesampour</LastName>
        <affiliation locale="en_US">Department of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Dabiri</LastName>
        <affiliation locale="en_US">Department of Microbiology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Javad</FirstName>
        <LastName>Arasteh</LastName>
        <affiliation locale="en_US">Department of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>10</Month>
        <Day>15</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>01</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Colorectal cancer is one of the deadliest cancers with poor prognosis and limited treatment options. Microbiota and their metabolites, including toxins, have been shown to possess anti-tumor properties. Outer membrane vesicles (OMVs) from Escherichia coli may trigger inflammation in intestinal cells. We aimed to explore the anti-cancer effects of E. coli-derived OMVs on colorectal cancer cells by promoting apoptosis and pyroptosis, particularly through the over-expression of GSDMD in the CT-26 cell line.
&#xD;

Methods: In 2022, five non-replicating probiotic strains of E. coli were obtained from the Histogenotech Company in Tehran, and their OMVs were isolated and characterized. The CT-26 cell line was used to assess cell toxicity and the apoptotic effects of E. coli-derived OMVs. Real-time PCR and western blotting were performed to measure the expression of apoptosis and pyroptosis markers (GSDMD, NLRP3, and ROCK).
&#xD;

Results: The E. coli strains produced nanovesicles (5-200 nm in diameter). OMVs significantly reduced the viability of CT-26 cells and induced apoptosis at a concentration of 10 &#xB5;g. The expression of GSDMD and NLRP3 was increased, while ROCK expression was downregulated in treated colorectal cells.
&#xD;

Conclusion: E. coli-derived OMVs can trigger inflammatory processes and induce negative effects on colorectal cancer cells. Further research is needed to evaluate their potential for colorectal cancer treatment.
&#xD;

&#xA0;
&#xD;

&#xA0;&#xA0; Keywords: E. coli; ; r; Apoptosis; Inflammation
&#xD;

&#xA0;</abstract>
    <web_url>https://ijph.tums.ac.ir/index.php/ijph/article/view/36927</web_url>
    <pdf_url>https://ijph.tums.ac.ir/index.php/ijph/article/download/36927/8583</pdf_url>
  </Article>
</Articles>
